Skip to main content

Table 3 Relative frequencies of the six possible orderings among the expression values of the top-scoring triple for various studies. .

From: The ordering of expression among a few genes can provide simple cancer biomarkers and signal BRCA1 mutations

   Colon Study DLBCL Study Leukemia Study
  Ordering Tumor Normal DLBCL FL ALL AML
π 1 X i <X j <X k 0.125 0.045 0.362 0 0.340 0
π 2 X i <X k <X j 0.4 0 0.569 0 0 0.04
π 3 X j <X i <X k 0.075 0.864 0.052 0 0.660 0
π 4 X j <X k <X i 0 0.091 0 0.684 0 0.08
π 5 X k <X i <X j 0.4 0 0.017 0.053 0 0.76
π 6 X k <X j <X i 0 0 0 0.263 0 0.12
   Prostate1 Study Lung Study GCM Study
  Ordering Cancer Normal MPM ADCA Tumor Normal
π 1 X i <X j <X k 0.04 0 0 0.12 0.8 0.222
π 2 X i <X k <X j 0.1 0 0 0.827 0.113 0.5
π 3 X k <X i <X k 0.02 0.115 0.258 0.007 0.079 0.022
π 4 X j <X k <X i 0.06 0.807 0.742 0 0 0.044
π 5 X k <X i <X j 0.5 0.019 0 0.02 0.008 0.179
π 6 X k <X j <X i 0.28 0.059 0 0.027 0 0.033
  1. Each portion of the corresponds to one study with two phenotypes. For each study and each phenotype, the table shows the relative frequencies of the six possible orderings among the expression values of the top-scoring triple for the samples in the study. The gene triple (g i , g j , g k ) for each study is given in Table 4
\